• ●India Valve Registry launched on 5 September 2026 by Vice President Shri C. P. Radhakrishnan at India Valves 2026 in Chennai.
• ●What it is: a collaborative multicentre registry collecting systematic, secure and de-identified real-world data on transcatheter valve interventions across India.
• ●Purpose: convert individual clinical experience into collective evidence on outcomes of heart valve interventions, generating India-specific data rather than importing foreign trial evidence.
• ●India Valves 2026 is a national academic meeting on valvular and structural heart disease drawing cardiologists, cardiac surgeons and researchers from India and abroad.
• ●A clinical registry differs from a clinical trial: it observes and records what happens in routine practice over time, instead of assigning patients to a treatment.
• ●Valvular heart disease in India carries a large rheumatic component; India recorded the world's highest number of deaths from rheumatic heart disease in 2015, over 119,000.
• ●The Vice-President of India is the ex-officio Chairman of the Rajya Sabha under Article 64 and is elected by an electoral college of both Houses of Parliament.
• ●Non-communicable disease control at the national level runs through the National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD), the renamed NPCDCS.

The India Valve Registry, launched in September 2026, systematically collects de-identified real-world data on which category of medical procedure?